Industry

Vaccines and Related Biological Products Advisory Committee will hold meeting on September 22, 2022 RBX2660 is an investigational microbiota-based live biotherapeutic studied for its potential to reduce recurrent C. difficile infection after antibiotic treatment SAINT-PREX, Switzerland & PARSIPPANY, N.J.–(BUSINESS WIRE)–#FDA–Ferring Pharmaceuticals today announced that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the … [Read more…]

Agreement generates upfront payment and ongoing revenues, validating the European opportunity for medical cannabis LONDON–(BUSINESS WIRE)–International medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced it has signed a multi-year supply agreement with European medical cannabis leader Cansativa GmbH (“Cansativa Group” or “Cansativa”) to supply EU-GMP quality THC dried flower … [Read more…]

PORTOLA VALLEY, Calif.–(BUSINESS WIRE)–TransMed7, LLC announced today that the first clinical cases of the final commercial production version of the Sparrow device (a member of the new SpeedBird™ family of vacuum-assisted, Single Insertion / Multiple Collection (SIMC®) Breast Biopsy devices) were successfully performed by Dr. Edgar Staren, a distinguished surgeon and former President of the … [Read more…]

Late-breaking oral presentation at WCLC features first results from TROPION-Lung02 trial of Daiichi Sankyo and AstraZeneca’s TROP2 directed antibody drug conjugate TOKYO & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Initial results from the TROPION-Lung02 phase 1b trial showed that datopotamab deruxtecan (Dato-DXd) in combination with pembrolizumab with or without platinum chemotherapy demonstrated promising clinical activity and a tolerable … [Read more…]

SEATTLE–(BUSINESS WIRE)–#spatialbiology–NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a peer-reviewed paper published in Nature Genetics using the GeoMx Human Whole Transcriptome Atlas (WTA) to construct a high-resolution molecular landscape of pancreatic cancer. This paper, along with a tissue image generated using the GeoMx® … [Read more…]

BOULDER, Colo.–(BUSINESS WIRE)–$BDSX #patientsfirst—Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced it has been recognized in the Healthcare Technology Report’s Top 100 Healthcare Technology Companies of 2022. The company develops and commercializes blood-based diagnostic tests designed to address important unmet needs in healthcare, by combining … [Read more…]

UPB-101 is a thymic stromal lymphopoietin receptor (TLSPR) blocker that inhibits signaling at the top of the inflammatory cascade WALTHAM, Mass.–(BUSINESS WIRE)–Upstream Bio, a clinical-stage biotech company advancing new therapies to treat inflammation, today announced the initiation of a Phase 1b multiple ascending dose study of UPB-101 in asthma patients and successful dosing of the … [Read more…]

Researchers find that doctors underestimate and caregivers overestimate symptoms LOS ANGELES–(BUSINESS WIRE)–A recent study reveals differences in how symptom toxicity is reported for children receiving cancer treatment in clinical trials. Doctors often underestimate or miss a child’s symptoms, while caregivers tend to overestimate symptoms. Children’s Hospital Los Angeles was one of nine hospitals that participated … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Advanced Hepatocellular Carcinoma with CPB Liver Cirrhosis – Market Insight, Epidemiology and Market Forecast -2032” report has been added to ResearchAndMarkets.com’s offering. This “Advanced Hepatocellular Carcinoma with CPB Liver Cirrhosis- Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Advanced Hepatocellular Carcinoma with CPB Liver Cirrhosis, historical and forecasted … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Dravet Syndrome Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 To 2029” report has been added to ResearchAndMarkets.com’s offering. Industry Outlook Dravet syndrome treatment accounted for a market value of US$ 258.1 Mn in 2020 and projected to grow at a CAGR of … [Read more…]